These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1919746)

  • 1. Differential myocardial washout of technetium-99m-teboroxime: mechanism and significance.
    Gewirtz H
    J Nucl Med; 1991 Oct; 32(10):2009-11. PubMed ID: 1919746
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there additional useful information in the myocardial washout characteristics of teboroxime?
    Nunn AD
    J Nucl Med; 1991 Oct; 32(10):1988-91. PubMed ID: 1919743
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive evaluation of myocardial perfusion with use of technetium-99m teboroxime.
    McGhie AI; Willerson JT
    J Am Coll Cardiol; 1992 Sep; 20(3):720-1. PubMed ID: 1512354
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart.
    Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
    J Nucl Med; 1991 Oct; 32(10):1979-88. PubMed ID: 1919742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
    Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
    J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
    Maublant JC; Moins N; Gachon P; Renoux M; Zhang Z; Veyre A
    J Nucl Med; 1993 Feb; 34(2):255-9. PubMed ID: 8429344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.
    Rumsey WL; Rosenspire KC; Nunn AD
    J Nucl Med; 1992 Jan; 33(1):94-101. PubMed ID: 1530970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic properties of myocardial perfusion tracers.
    Dahlberg ST; Leppo JA
    Cardiol Clin; 1994 May; 12(2):169-85. PubMed ID: 8033171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
    Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
    J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis.
    Gray WA; Gewirtz H
    Circulation; 1991 Oct; 84(4):1796-807. PubMed ID: 1914115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ; Leppo JA
    Am J Cardiol; 1990 Oct; 66(13):9E-15E. PubMed ID: 2145753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress.
    Stewart RE; Heyl B; O'Rourke RA; Blumhardt R; Miller DD
    J Nucl Med; 1991 Oct; 32(10):2000-8. PubMed ID: 1919745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography].
    Bisi G; Sciagrà R; Santoro GM; Cerisano G; Vella A; Zerauschek F; Fazzini PF
    G Ital Cardiol; 1992 Jul; 22(7):795-805. PubMed ID: 1473653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R
    Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
    Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
    J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial clearance kinetics of technetium-99m-teboroxime following dipyridamole injection.
    Gewirtz H
    J Nucl Med; 1995 Jan; 36(1):119-20. PubMed ID: 7799063
    [No Abstract]   [Full Text] [Related]  

  • 19. Technetium-99m teboroxime regional myocardial washout in subjects with and without coronary artery disease.
    Chua T; Kiat H; Germano G; Palmas W; Takemoto K; Friedman J; Berman DS
    Am J Cardiol; 1993 Sep; 72(9):728-34. PubMed ID: 8249853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracer selection with different stress modalities based on tracer kinetics.
    Heller GV
    J Nucl Cardiol; 1996; 3(6 Pt 2):S15-21. PubMed ID: 8989682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.